JP2023545359A5 - - Google Patents
Info
- Publication number
- JP2023545359A5 JP2023545359A5 JP2023515569A JP2023515569A JP2023545359A5 JP 2023545359 A5 JP2023545359 A5 JP 2023545359A5 JP 2023515569 A JP2023515569 A JP 2023515569A JP 2023515569 A JP2023515569 A JP 2023515569A JP 2023545359 A5 JP2023545359 A5 JP 2023545359A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- adc
- cell
- pharmaceutical composition
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063077604P | 2020-09-12 | 2020-09-12 | |
| US63/077,604 | 2020-09-12 | ||
| PCT/IB2021/058273 WO2022054009A2 (en) | 2020-09-12 | 2021-09-11 | A scoring method for an anti-her2 antibody-drug conjugate therapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023545359A JP2023545359A (ja) | 2023-10-30 |
| JP2023545359A5 true JP2023545359A5 (https=) | 2024-09-11 |
Family
ID=77801755
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023515569A Pending JP2023545359A (ja) | 2020-09-12 | 2021-09-11 | 抗ｈｅｒ２抗体－薬物複合体治療のためのスコアリング方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240426826A1 (https=) |
| EP (1) | EP4211598B1 (https=) |
| JP (1) | JP2023545359A (https=) |
| KR (1) | KR20230066094A (https=) |
| CN (1) | CN116601713A (https=) |
| AU (2) | AU2021340002B9 (https=) |
| CA (1) | CA3195062A1 (https=) |
| ES (1) | ES3064041T3 (https=) |
| IL (1) | IL301265A (https=) |
| WO (1) | WO2022054009A2 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20240037740A1 (en) * | 2022-07-28 | 2024-02-01 | Applied Materials, Inc. | Method and system for automatic ihc marker-her2 score |
| EP4623936A1 (en) * | 2022-11-22 | 2025-10-01 | Keymed Biosciences (Chengdu) Co., Ltd. | Fused ring compound, conjugate thereof and use thereof |
| WO2025103192A1 (zh) * | 2023-11-16 | 2025-05-22 | 上海齐鲁制药研究中心有限公司 | 一种氘代喜树碱化合物及其制备和应用 |
| WO2025162211A1 (zh) * | 2024-01-29 | 2025-08-07 | 正大天晴药业集团股份有限公司 | 抗her2抗体药物偶联物治疗胃癌的用途 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL162181A (en) | 1988-12-28 | 2006-04-10 | Pdl Biopharma Inc | A method of producing humanized immunoglubulin, and polynucleotides encoding the same |
| EP1400536A1 (en) | 1991-06-14 | 2004-03-24 | Genentech Inc. | Method for making humanized antibodies |
| DK1071700T3 (da) | 1998-04-20 | 2010-06-07 | Glycart Biotechnology Ag | Glykosylerings-modifikation af antistoffer til forbedring af antistofafhængig cellulær cytotoksicitet |
| CA2953239A1 (en) | 2000-10-06 | 2002-04-18 | Kyowa Hakko Kirin Co., Ltd. | Antibody composition-producing cell |
| EP2854851A4 (en) * | 2012-06-01 | 2016-03-30 | Momenta Pharmaceuticals Inc | Methods related to trastuzumab |
| IL310627B2 (en) * | 2014-01-31 | 2026-04-01 | Daiichi Sankyo Co Ltd | Anti-HER2 antibody-drug conjugates, compositions containing them and uses thereof |
| GB201502590D0 (en) * | 2015-02-16 | 2015-04-01 | Lonza Ag | Method and apparatus for designing proteins |
| MX2017015260A (es) * | 2015-06-03 | 2018-02-19 | Squibb Bristol Myers Co | Anticuerpos anti receptor de factor de necrosis tumoral inducible por glucocorticoide (gitr) para diagnostico del cancer. |
| CN110651189B (zh) * | 2017-03-03 | 2024-10-25 | 特雷斯生物有限公司 | 肽疫苗 |
| EP3659110A1 (en) * | 2017-07-24 | 2020-06-03 | Ventana Medical Systems, Inc. | Methods and systems for evaluation of immune cell infiltrate in tumor samples |
| EP3721373B1 (en) * | 2017-12-07 | 2025-03-05 | Ventana Medical Systems, Inc. | Deep-learning systems and methods for joint cell and region classification in biological images |
| EP3797296B1 (en) * | 2018-05-21 | 2024-09-04 | Genentech, Inc. | Her2 heterogeneity as a biomarker in cancer |
| US11030744B2 (en) * | 2018-06-26 | 2021-06-08 | Astrazeneca Computational Pathology Gmbh | Deep learning method for tumor cell scoring on cancer biopsies |
| US12020493B2 (en) * | 2018-07-27 | 2024-06-25 | Ventana Medical Systems, Inc. | Systems for automated in situ hybridization analysis |
| WO2022162164A1 (en) * | 2021-01-29 | 2022-08-04 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods of assessing the risk of developing progressive multifocal leukoencephalopathy in patients treated with vla-4 antagonists |
-
2021
- 2021-09-11 CN CN202180077294.6A patent/CN116601713A/zh active Pending
- 2021-09-11 WO PCT/IB2021/058273 patent/WO2022054009A2/en not_active Ceased
- 2021-09-11 IL IL301265A patent/IL301265A/en unknown
- 2021-09-11 EP EP21772839.3A patent/EP4211598B1/en active Active
- 2021-09-11 KR KR1020237012303A patent/KR20230066094A/ko active Pending
- 2021-09-11 AU AU2021340002A patent/AU2021340002B9/en active Active
- 2021-09-11 CA CA3195062A patent/CA3195062A1/en active Pending
- 2021-09-11 JP JP2023515569A patent/JP2023545359A/ja active Pending
- 2021-09-11 ES ES21772839T patent/ES3064041T3/es active Active
- 2021-09-11 US US18/025,896 patent/US20240426826A1/en active Pending
-
2024
- 2024-09-17 AU AU2024219803A patent/AU2024219803A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023545359A5 (https=) | ||
| Goetz et al. | In vivo molecular imaging of colorectal cancer with confocal endomicroscopy by targeting epidermal growth factor receptor | |
| JP2023542066A5 (https=) | ||
| Moore et al. | Effects of an unlabeled loading dose on tumor-specific uptake of a fluorescently labeled antibody for optical surgical navigation | |
| JP5586368B2 (ja) | 腫瘍マーカーとしてのｎ１，ｎ１２−ジアセチルスペルミン | |
| Li et al. | In vivo molecular imaging of gastric cancer by targeting MG7 antigen with confocal laser endomicroscopy | |
| JP2025509564A5 (https=) | ||
| WO2020097336A1 (en) | Cdcp1-targeted therapies | |
| RU2750817C1 (ru) | Применение конъюгата анти-her2 антитело-лекарственное средство при лечении уротелиальной карциномы | |
| JP2023545096A5 (https=) | ||
| IL273252B2 (en) | Compositions and methods for predicting response to napi2b-targeted therapy | |
| CN116601713A (zh) | 用于抗her2抗体-药物缀合物疗法的评分方法 | |
| CN117980007A (zh) | c－KIT阳性肿瘤特异性抗体片段 | |
| JP2024545428A5 (https=) | ||
| JP2019524706A5 (https=) | ||
| JP2025509564A (ja) | 抗ｔｒｏｐ２抗体－薬物コンジュゲート治療のためのスコアリング方法 | |
| CN107949385B (zh) | 荧光缀合物 | |
| JP2023542301A5 (https=) | ||
| Liu et al. | Enhanced visualization of colonic polyps using a fluorophore-conjugated claudin-1 antibody in a CPC-APC mouse model | |
| WO2025055589A1 (en) | Methods of treating cervical cancer using anti-her2 antibody-drug conjugates | |
| CN113754764B (zh) | 抗dog-1抗体、缀合物、药物组合物、药物制剂及其用途 | |
| CN120053679A (zh) | 一种靶向CD66c的抗体偶联药物及其在制备胃食管结合部癌治疗药物中的用途 | |
| CN116930494A (zh) | Icam1或其编码基因在制备宫颈癌治疗或诊断产品中的用途 | |
| JP2025503511A5 (https=) | ||
| Lauwerends | Zweedi k, BE, Galema, H.., Nei enhuis, LK |